Oppenheimer: Teva Is Now Worth $77/Share, More Deals To Come By: Benzinga via Benzinga March 31, 2015 at 10:30 AM EDT Oppenheimer upgraded Teva Pharmaceutical Industries Ltd (ADR) (NYSE: TEVA) Tuesday from Perform to Outperform and set a price target ... Read More >> Related Stocks: Mallinckrodt plc Teva Pharmaceutical Industries ADR